112 related articles for article (PubMed ID: 9574811)
1. S-(1,2-dichlorovinyl)-L-cysteine-induced dedifferentiation and p53 gene mutations in LLC-PK1 cells: a comparative investigation with S-(2-chloroethyl)cysteine, potassium bromate, cis-platinum and styrene oxide.
Richter H; Vamvakas S
Toxicol Lett; 1998 Jan; 94(2):145-57. PubMed ID: 9574811
[TBL] [Abstract][Full Text] [Related]
2. Induction of dedifferentiated clones of LLC-PK1 cells upon long-term exposure to dichlorovinylcysteine.
Vamvakas S; Richter H; Bittner D
Toxicology; 1996 Jan; 106(1-3):65-74. PubMed ID: 8571403
[TBL] [Abstract][Full Text] [Related]
3. Events that precede and that follow S-(1,2-dichlorovinyl)-L-cysteine-induced release of mitochondrial Ca2+ and their association with cytotoxicity to renal cells.
Vamvakas S; Bittner D; Dekant W; Anders MW
Biochem Pharmacol; 1992 Sep; 44(6):1131-8. PubMed ID: 1417936
[TBL] [Abstract][Full Text] [Related]
4. Induction of poly(ADP-ribosyl)ation in the kidney after in vivo application of renal carcinogens.
McLaren J; Boulikas T; Vamvakas S
Toxicology; 1994 Mar; 88(1-3):101-12. PubMed ID: 8160192
[TBL] [Abstract][Full Text] [Related]
5. The role of glutathione conjugate metabolism and cysteine conjugate beta-lyase in the mechanism of S-cysteine conjugate toxicity in LLC-PK1 cells.
Stevens J; Hayden P; Taylor G
J Biol Chem; 1986 Mar; 261(7):3325-32. PubMed ID: 3753976
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin-induced toxicity is associated with platinum deposition in mouse kidney mitochondria in vivo and with selective inactivation of the alpha-ketoglutarate dehydrogenase complex in LLC-PK1 cells.
Zhang L; Cooper AJ; Krasnikov BF; Xu H; Bubber P; Pinto JT; Gibson GE; Hanigan MH
Biochemistry; 2006 Jul; 45(29):8959-71. PubMed ID: 16846239
[TBL] [Abstract][Full Text] [Related]
7. Oxidative DNA damage induced by potassium bromate under cell-free conditions and in mammalian cells.
Ballmaier D; Epe B
Carcinogenesis; 1995 Feb; 16(2):335-42. PubMed ID: 7859366
[TBL] [Abstract][Full Text] [Related]
8. Analysis of renal cell transformation following exposure to trichloroethene in vivo and its metabolite S-(dichlorovinyl)-L-cysteine in vitro.
Mally A; Walker CL; Everitt JI; Dekant W; Vamvakas S
Toxicology; 2006 Jul; 224(1-2):108-18. PubMed ID: 16730402
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity frequency at the Trp53 locus in p53-deficient (+/-) mouse tumors is carcinogen-and tissue-dependent.
French JE; Lacks GD; Trempus C; Dunnick JK; Foley J; Mahler J; Tice RR; Tennant RW
Carcinogenesis; 2001 Jan; 22(1):99-106. PubMed ID: 11159747
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of S-(1,2,3,4,4-pentachlorobutadienyl)-L cysteine after apical and basolateral exposure of LLC-PK monolayers. Involvement of an amino acid transport system.
Mertens JJ; Keukens EA; Appel M; Spenkelink B; Temmink JH; van Bladeren PJ
Chem Biol Interact; 1990; 75(1):119-30. PubMed ID: 2364456
[TBL] [Abstract][Full Text] [Related]
11. The nephrotoxin dichlorovinylcysteine induces expression of the protooncogenes c-fos and c-myc in LLC-PK1 cells--a comparative investigation with growth factors and 12-O-tetradecanoylphorbolacetate.
Vamvakas S; Köster U
Cell Biol Toxicol; 1993; 9(1):1-13. PubMed ID: 7686084
[TBL] [Abstract][Full Text] [Related]
12. The transport of S-cysteine conjugates in LLC-PK1 cells and its role in toxicity.
Schaeffer VH; Stevens JL
Mol Pharmacol; 1987 May; 31(5):506-12. PubMed ID: 2883569
[TBL] [Abstract][Full Text] [Related]
13. Assessment of unscheduled DNA synthesis in a cultured line of renal epithelial cells exposed to cysteine S-conjugates of haloalkenes and haloalkanes.
Vamvakas S; Dekant W; Henschler D
Mutat Res; 1989 Apr; 222(4):329-35. PubMed ID: 2704384
[TBL] [Abstract][Full Text] [Related]
14. The effects of haloalkene cysteine conjugates on cytosolic free calcium levels in LLC-PK(1) cells--studies utilising digital imaging fluorescence microscopy.
Blackmore M; Whitwell C; Morton JK; Gray TJ; Lock EA
Toxicology; 2002 Jun; 175(1-3):143-52. PubMed ID: 12049843
[TBL] [Abstract][Full Text] [Related]
15. Quiescent LLC-PK1 cells as a model for cis-diamminedichloroplatinum(II) nephrotoxicity and modulation by thiol rescue agents.
Montine TJ; Borch RF
Cancer Res; 1988 Nov; 48(21):6017-24. PubMed ID: 2458831
[TBL] [Abstract][Full Text] [Related]
16. Signalling the molecular stress response to nephrotoxic and mutagenic cysteine conjugates: differential roles for protein synthesis and calcium in the induction of c-fos and c-myc mRNA in LLC-PK1 cells.
Yu K; Chen Q; Liu H; Zhan Y; Stevens JL
J Cell Physiol; 1994 Nov; 161(2):303-11. PubMed ID: 7962114
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin-induced toxicity in LLC-PK1 kidney epithelial cells: role of basolateral membrane transport.
Okuda M; Tsuda K; Masaki K; Hashimoto Y; Inui K
Toxicol Lett; 1999 Jun; 106(2-3):229-35. PubMed ID: 10403667
[TBL] [Abstract][Full Text] [Related]
18. Role of mitochondrial dysfunction in S-(1,2-dichlorovinyl)-l-cysteine-induced apoptosis.
Chen Y; Cai J; Anders MW; Stevens JL; Jones DP
Toxicol Appl Pharmacol; 2001 Feb; 170(3):172-80. PubMed ID: 11162782
[TBL] [Abstract][Full Text] [Related]
19. Cysteine S-conjugates activate transcription factor NF-kappa B in cultured renal epithelial cells.
Otieno MA; Anders MW
Am J Physiol; 1997 Jul; 273(1 Pt 2):F136-43. PubMed ID: 9249601
[TBL] [Abstract][Full Text] [Related]
20. Formation of three N-acetyl-L-cysteine monoadducts and one diadduct by the reaction of S-(1,2-dichlorovinyl)-L-cysteine sulfoxide with N-acetyl-L-cysteine at physiological conditions: chemical mechanisms and toxicological implications.
Barshteyn N; Elfarra AA
Chem Res Toxicol; 2007 Oct; 20(10):1563-9. PubMed ID: 17892265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
